A single reagent for any payload.
Valentrifect™ Omni+ delivers messenger RNA, plasmid DNA and self-amplifying RNA on the same hybrid lipid nanoparticle platform. A lab running mixed payloads stocks and optimizes one reagent instead of three.
Every payload, measured side by side.
Omni+ against the reagent a lab would otherwise reach for, payload by payload: Lipofectamine™ MessengerMAX for RNA and Lipofectamine™ 3000 for plasmid DNA.
Percent of cells transfected, mean ± 2 percentage points (± 3 for A549 plasmid DNA). Luciferase rows are firefly luciferase signal, not percent of cells; each run carries its own units, so those numbers are comparable within a pair and not between pairs. Each pair is scaled on its own, so bar length compares Omni+ with its comparator within that row and not between rows. Internal data.
Why one reagent matters.
A lab that runs mRNA one week and plasmid the next currently stocks two or three reagents, each with its own conditions to optimize and its own line on the order. Omni+ covers all three, and self-amplifying RNA, the largest and hardest RNA to deliver, is where it leads most clearly.
It is not ahead everywhere. On plasmid DNA, Omni+ is level with Lipofectamine™ 3000 in PC-3 and HEK293T and behind it in HeLa and A549. That is where our development work is pointed, and the figures above are shown as they stand.
Interested in Omni+?
Tell us about your cell lines and your RNA. We would like to hear what you need.
For research use only. Not for diagnostic or therapeutic use. Lipofectamine™, MessengerMAX™ and ExpiFectamine™ are trademarks of Thermo Fisher Scientific, which is not affiliated with Valentris.
